Drug Trial Radar · NCT04188509
Open-Label Extension of Voxelotor
Last checked: Nov 20, 2026Latest source record: Nov 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
162
Actual
Start
Nov 18, 2019
Primary completion
Nov 1, 2024
Study completion Nov 1, 2024
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Dec 6, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Open-label extension study of voxelotor for participants with Sickle Cell Disease who have participated in voxelotor clinical trials.
Conditions
- Sickle Cell Disease
Interventions
VoxelotorDrug
All participants will receive voxelotor once daily (QD), administered orally as tablets, dispersible tablets, or a powder for oral suspension formulation (powder formulation packaged as stick packs).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment Emergent Adverse Events (AEs)Time frame: From date of informed consent until 28 days after last dose of study drug (maximum up to 4.31 years)
- Number of Participants With SAEsTime frame: From date of informed consent until 28 days after last dose of study drug (maximum up to 4.31 years)
- Number of Participants With Sickle Cell Disease (SCD) Related TEAEs and SAEsTime frame: From date of informed consent until 28 days after last dose of study drug (maximum up to 4.31 years)
Locations
20 sites in 5 countries. Site status is shown where the registry gives one.
Children's National Medical Center
Washington D.C., District of Columbia
Children's Healthcare of Atlanta Scottish Rite
Atlanta, Georgia
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Children's Mercy Hospital
Kansas City, Missouri
ECU Physicians, Brody Outpatient Clinic
Greenville, North Carolina
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania
Alexandria University Hospital - Clinical Research Center
Alexandria, Egypt
Cairo University Hospital, Abu El Rish Hospital
Cairo, Egypt
Ain Shams University Hospital - Clinical Research Center (MASRI-CRC)
Cairo, Egypt
Zagazig University Hospital
Zagazig, Alsharkia, Egypt
American University of Beirut - Medical Center
Beirut, Lebanon
Nini Hospital
Tripoli, Lebanon
Barau Dikko Teaching Hospital/Kaduna State University
Kaduna, Nigeria
Aminu Kano Teaching Hospital
Kano, Nigeria
Lagos University Teaching Hospital
Lagos, Nigeria
University of Calabar Teaching Hospital
Calabar, Cross River State, Nigeria
College of Medicine, University of Ibadan
Ibadan, Oyo State, Nigeria
Barts Health NHS Trust , The Royal London Hospital
London, United Kingdom
Guy'S and St Thomas' Nhs Foundation Trust
London, United Kingdom
University College Hospital NHS Foundation Trust
London, Greater London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.